ICD-10-CM Billable Code

M08.959

Juvenile arthritis, unspecified, unspecified hip

Clinical Classification Guidelines

Medical Intelligence & Overview

Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a term used to describe a group of inflammatory joint disorders affecting children under the age of 16. When it involves the hip joint without a specific subtype identified, it is classified under ICD-10 code M08.959. This condition can cause pain, swelling, and limited movement in the affected joint, impacting a child's daily activities and quality of life. While the exact cause remains unknown, ongoing research aims to better understand the triggers and risk factors associated with juvenile arthritis.

Causes & Symptoms

Clinical Causes: Genetic predisposition, including family history of autoimmune diseases Immune system malfunctions that attack joint tissues Environmental factors such as infections or environmental toxins Hormonal influences, although not fully understood Possible links to other autoimmune conditions

Key Symptoms: Persistent joint pain or tenderness, especially in the hip Swelling around the affected joint Reduced range of motion or stiffness, particularly after periods of inactivity Limping due to joint discomfort or limited mobility Warmth or redness around the joint General symptoms such as fever, fatigue, or rash (less common but may occur in systemic forms)

Diagnostic & Treatment

Diagnosis Path: Diagnosis of juvenile arthritis in the hip involves a comprehensive evaluation, including medical history and physical examination. Tests may include blood work to identify inflammation markers, imaging studies such as X-rays or MRI scans to visualize joint damage or swelling, and sometimes joint fluid analysis to rule out other conditions. Given the absence of specific tests for juvenile arthritis, diagnosis primarily relies on clinical findings and the exclusion of other potential causes of joint symptoms.

Treatment Protocols: Management of juvenile arthritis aims to control inflammation, alleviate pain, and maintain joint function. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain - Physical therapy to improve joint flexibility and muscle strength - Regular exercise tailored to the child's abilities - Corticosteroid injections in cases of localized inflammation - Disease-modifying antirheumatic drugs (DMARDs) in more severe cases - Monitoring for potential side effects and disease progression It is essential for children with juvenile arthritis to receive ongoing medical care to adapt treatment plans as needed and support healthy growth and development.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.959 a billable ICD-10 code?
Yes, M08.959 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.959?
Clinical documentation must specify the nature of Juvenile arthritis, unspecified, unspecified hip and any associated comorbidities for accurate reporting.

Cite this Clinical Reference